TR200000786T2 - Vitronektin reseptör antagonisti - Google Patents
Vitronektin reseptör antagonistiInfo
- Publication number
- TR200000786T2 TR200000786T2 TR2000/00786T TR200000786T TR200000786T2 TR 200000786 T2 TR200000786 T2 TR 200000786T2 TR 2000/00786 T TR2000/00786 T TR 2000/00786T TR 200000786 T TR200000786 T TR 200000786T TR 200000786 T2 TR200000786 T2 TR 200000786T2
- Authority
- TR
- Turkey
- Prior art keywords
- receptor antagonist
- vitronectin receptor
- vitronectin
- osteoporosis
- useful
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Bir vitronektin reseptörü antagonisti olup osteoporoz tedavisinde yararli olan bir formül (1) bilesimi veya farmasötik olarak kabul edilebilir bir tuzu açiklanmaktadir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5986797P | 1997-09-24 | 1997-09-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200000786T2 true TR200000786T2 (tr) | 2000-08-21 |
Family
ID=22025805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/00786T TR200000786T2 (tr) | 1997-09-24 | 1998-09-24 | Vitronektin reseptör antagonisti |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1023073A1 (tr) |
JP (1) | JP2002500162A (tr) |
KR (1) | KR20010024249A (tr) |
CN (1) | CN1271284A (tr) |
AU (1) | AU9578798A (tr) |
BR (1) | BR9813214A (tr) |
CA (1) | CA2304000A1 (tr) |
HU (1) | HUP0003931A2 (tr) |
IL (1) | IL135188A0 (tr) |
NO (1) | NO20001515L (tr) |
PL (1) | PL339414A1 (tr) |
TR (1) | TR200000786T2 (tr) |
WO (1) | WO1999015178A1 (tr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000046215A1 (en) | 1999-02-03 | 2000-08-10 | Merck & Co., Inc. | Benzazepine derivatives as alpha-v integrin receptor antagonists |
US6514964B1 (en) | 1999-09-27 | 2003-02-04 | Amgen Inc. | Fused cycloheptane and fused azacycloheptane compounds and their methods of use |
RU2316337C2 (ru) | 2001-04-24 | 2008-02-10 | Мерк Патент Гмбх | КОМБИНИРОВАННАЯ ТЕРАПИЯ, ИСПОЛЬЗУЮЩАЯ АНТИАНГИОГЕННЫЕ СРЕДСТВА И TNF-α |
WO2003059251A2 (en) | 2001-10-22 | 2003-07-24 | The Scripps Research Institute | Antibody targeting compounds |
US7368566B2 (en) | 2003-04-04 | 2008-05-06 | Smithkline Beecham Corporation | Process and intermediates for preparing benzazepines |
DE602005012233D1 (de) | 2004-02-02 | 2009-02-26 | Pioneer Hi Bred Int | Ap2-domäne-transkriptionsfaktor odp2 (ovule development protein 2) und verwendungsverfahren |
UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
EP1973569B1 (en) | 2006-01-18 | 2013-05-22 | Merck Patent GmbH | Specific therapy using integrin ligands for treating cancer |
PL2101805T3 (pl) | 2007-01-18 | 2013-04-30 | Merck Patent Gmbh | Ligandy integryn do stosowania w leczeniu nowotworów |
AU2008321770B2 (en) * | 2007-11-16 | 2012-09-06 | Ube Industries, Ltd. | Benzazepinone compound |
US8076475B2 (en) * | 2008-03-06 | 2011-12-13 | Glaxosmithkline Llc | Process |
WO2010093706A2 (en) | 2009-02-10 | 2010-08-19 | The Scripps Research Institute | Chemically programmed vaccination |
EP2415474B1 (en) | 2009-03-30 | 2013-08-28 | Ube Industries, Ltd. | Pharmaceutical composition for treatment or prevention of ophthalmic diseases |
WO2010136168A2 (en) | 2009-05-25 | 2010-12-02 | Merck Patent Gmbh | Continuous administration of integrin ligands for treating cancer |
CN102892888A (zh) | 2009-12-30 | 2013-01-23 | 先锋国际良种公司 | 在植物中导入并调节表达基因的方法和组合物 |
CA2793596A1 (en) | 2009-12-30 | 2011-07-07 | Pioneer Hi-Bred International, Inc. | Methods and compositions for targeted polynucleotide modification |
WO2015181676A1 (en) | 2014-05-30 | 2015-12-03 | Pfizer Inc. | Carbonitrile derivatives as selective androgen receptor modulators |
WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA60311C2 (uk) * | 1996-10-02 | 2003-10-15 | Смітклайн Бічам Корпорейшн | Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція |
-
1998
- 1998-09-24 IL IL13518898A patent/IL135188A0/xx unknown
- 1998-09-24 KR KR1020007003093A patent/KR20010024249A/ko not_active Application Discontinuation
- 1998-09-24 CA CA002304000A patent/CA2304000A1/en not_active Abandoned
- 1998-09-24 BR BR9813214-8A patent/BR9813214A/pt not_active Application Discontinuation
- 1998-09-24 HU HU0003931A patent/HUP0003931A2/hu unknown
- 1998-09-24 TR TR2000/00786T patent/TR200000786T2/tr unknown
- 1998-09-24 WO PCT/US1998/019987 patent/WO1999015178A1/en not_active Application Discontinuation
- 1998-09-24 PL PL98339414A patent/PL339414A1/xx unknown
- 1998-09-24 JP JP2000512547A patent/JP2002500162A/ja not_active Withdrawn
- 1998-09-24 AU AU95787/98A patent/AU9578798A/en not_active Abandoned
- 1998-09-24 EP EP98949471A patent/EP1023073A1/en active Pending
- 1998-09-24 CN CN98809494A patent/CN1271284A/zh active Pending
-
2000
- 2000-03-23 NO NO20001515A patent/NO20001515L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU9578798A (en) | 1999-04-12 |
IL135188A0 (en) | 2001-05-20 |
HUP0003931A2 (hu) | 2001-10-28 |
NO20001515D0 (no) | 2000-03-23 |
NO20001515L (no) | 2000-03-23 |
PL339414A1 (en) | 2000-12-18 |
EP1023073A1 (en) | 2000-08-02 |
CA2304000A1 (en) | 1999-04-01 |
JP2002500162A (ja) | 2002-01-08 |
CN1271284A (zh) | 2000-10-25 |
BR9813214A (pt) | 2000-08-29 |
KR20010024249A (ko) | 2001-03-26 |
WO1999015178A1 (en) | 1999-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200000786T2 (tr) | Vitronektin reseptör antagonisti | |
TR199801253T2 (tr) | Vitronektin reseptörü antagonistleri. | |
MX9805253A (es) | Antagonistas del receptor de vitronectina. | |
BG106585A (en) | Kinase inhibitors as therapeutic agents | |
TR199700844T1 (tr) | Pirazolil-Benzoil Türevleri. | |
BR0014651A (pt) | Inibidores de adesão de célula mediada por "alfa" l beta2 | |
MX9700041A (es) | Antagonistas de receptor de vitronectina. | |
ATE306261T1 (de) | Antithrombosemittel | |
TR200100432T2 (tr) | Hepatit C inhibitörü tri-peptidler | |
DK0977741T3 (da) | Substituerede phenylderivater, deres fremstilling og anvendelse | |
NO20001514L (no) | Vitronectin-reseptor-antagonist | |
TR200000721T2 (tr) | Vitronektin reseptör antagonistleri. | |
TR199902283T2 (tr) | Ikame edilmis izokuinolin türevleri ve bunlarin antikonvulsant olarak kullanimi. | |
ES2182349T3 (es) | Procedimiento de orto-metalizacion para la sintesis de 1-(tetrazol-5-il)bencenos sustituidos en la posicion 2. | |
NO975975L (no) | Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav | |
TR200101654T2 (tr) | Vitronektin reseptr antagonistleri | |
DE60112960D1 (de) | Kondensierte pyridoindolderivate | |
TR200200614T2 (tr) | Vitronektin reseptörü antagonistleri | |
ATE284871T1 (de) | Bicyclische vasopressin-agoniste | |
CA2278057A1 (en) | Tachykinin antagonists | |
FR2796829B1 (fr) | Plaque d'osteotomie tibiale | |
DE60121048D1 (de) | PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
DK0896822T3 (da) | 4-aminopyrrol (3,2-d) pyrimidiner som neuropeptide Y receptorantagonister | |
HRP20010885B1 (en) | Ethanesulfonyl-piperidine derivatives | |
WO2000007544A3 (en) | Vitronectin receptor antagonists |